List of Tables
    Table 1. Key Players of Tumor Necrosis Factor Inhibitor Drug in Global Market
    Table 2. Top Tumor Necrosis Factor Inhibitor Drug Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Tumor Necrosis Factor Inhibitor Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Tumor Necrosis Factor Inhibitor Drug Revenue Share by Companies, 2017-2022
    Table 5. Global Tumor Necrosis Factor Inhibitor Drug Sales by Companies, (K Units), 2017-2022
    Table 6. Global Tumor Necrosis Factor Inhibitor Drug Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Tumor Necrosis Factor Inhibitor Drug Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Tumor Necrosis Factor Inhibitor Drug Product Type
    Table 9. List of Global Tier 1 Tumor Necrosis Factor Inhibitor Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Tumor Necrosis Factor Inhibitor Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2017-2022
    Table 15. By Type - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2023-2028
    Table 16. By Application – Global Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2017-2022
    Table 20. By Application - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2023-2028
    Table 21. By Region – Global Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Tumor Necrosis Factor Inhibitor Drug Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2017-2022
    Table 25. By Region - Global Tumor Necrosis Factor Inhibitor Drug Sales (K Units), 2023-2028
    Table 26. By Country - North America Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2017-2022
    Table 29. By Country - North America Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2023-2028
    Table 38. By Country - South America Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2017-2022
    Table 41. By Country - South America Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Sales, (K Units), 2023-2028
    Table 46. AbbVie Inc. Corporate Summary
    Table 47. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 48. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. Amgen Inc. Corporate Summary
    Table 50. Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 51. Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Johnson & Johnson Corporate Summary
    Table 53. Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 54. Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. UCB Corporate Summary
    Table 56. UCB Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 57. UCB Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Novartis AG Corporate Summary
    Table 59. Novartis AG Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 60. Novartis AG Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Pfizer, Inc. Corporate Summary
    Table 62. Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 63. Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Merck & Co., Inc. Corporate Summary
    Table 65. Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 66. Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. CASI Pharmaceuticals Corporate Summary
    Table 68. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 69. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. EPIRUS Biopharmaceuticals Corporate Summary
    Table 71. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 72. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. LEO Pharma Corporate Summary
    Table 74. LEO Pharma Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 75. LEO Pharma Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. PROBIOMED Corporate Summary
    Table 77. PROBIOMED Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 78. PROBIOMED Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 79. Shanghai Pharmaceuticals Holding Co., Ltd. Corporate Summary
    Table 80. Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Product Offerings
    Table 81. Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 82. Tumor Necrosis Factor Inhibitor Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 83. Global Tumor Necrosis Factor Inhibitor Drug Capacity Market Share of Key Manufacturers, 2020-2022
    Table 84. Global Tumor Necrosis Factor Inhibitor Drug Production by Region, 2017-2022 (K Units)
    Table 85. Global Tumor Necrosis Factor Inhibitor Drug Production by Region, 2023-2028 (K Units)
    Table 86. Tumor Necrosis Factor Inhibitor Drug Market Opportunities & Trends in Global Market
    Table 87. Tumor Necrosis Factor Inhibitor Drug Market Drivers in Global Market
    Table 88. Tumor Necrosis Factor Inhibitor Drug Market Restraints in Global Market
    Table 89. Tumor Necrosis Factor Inhibitor Drug Raw Materials
    Table 90. Tumor Necrosis Factor Inhibitor Drug Raw Materials Suppliers in Global Market
    Table 91. Typical Tumor Necrosis Factor Inhibitor Drug Downstream
    Table 92. Tumor Necrosis Factor Inhibitor Drug Downstream Clients in Global Market
    Table 93. Tumor Necrosis Factor Inhibitor Drug Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Tumor Necrosis Factor Inhibitor Drug Segment by Type
    Figure 2. Tumor Necrosis Factor Inhibitor Drug Segment by Application
    Figure 3. Global Tumor Necrosis Factor Inhibitor Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Tumor Necrosis Factor Inhibitor Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Tumor Necrosis Factor Inhibitor Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. Tumor Necrosis Factor Inhibitor Drug Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Tumor Necrosis Factor Inhibitor Drug Revenue in 2021
    Figure 9. By Type - Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 10. By Type - Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 13. By Application - Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Tumor Necrosis Factor Inhibitor Drug Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 16. By Region - Global Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 19. US Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 24. Germany Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. France Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 33. China Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. India Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 40. Brazil Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Tumor Necrosis Factor Inhibitor Drug Sales Market Share, 2017-2028
    Figure 44. Turkey Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Tumor Necrosis Factor Inhibitor Drug Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Tumor Necrosis Factor Inhibitor Drug Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Tumor Necrosis Factor Inhibitor Drug by Region, 2021 VS 2028
    Figure 50. Tumor Necrosis Factor Inhibitor Drug Industry Value Chain
    Figure 51. Marketing Channels